細胞庫外包市場規模、佔有率和成長分析（按類型、產品、細胞類型、階段和地區分類）－2026-2033年產業預測

預計到 2024 年，全球細胞庫外包市場規模將達到 155.9 億美元，到 2025 年將達到 182.7 億美元，到 2033 年將達到 650.4 億美元，預測期（2026-2033 年）的複合年成長率為 17.2%。

全球細胞庫外包市場預計將迎來顯著成長，這主要得益於冷凍保存技術和細胞庫製備調查方法的進步。幹細胞療法日益普及以及對單株抗體和高效的生物製藥需求的不斷成長，是推動該市場發展的重要因素。此外，政府的支持性政策以及細胞株保存和鑑定技術的進步也為市場成長注入了動力。主要產業參與者之間的重要合作，尤其是在研發領域的合作，預計將進一步加速市場成長。對用於提高組織在冷凍保存過程中穩定性的冷凍保護劑的研究，預計也將對市場格局產生正面影響。總而言之，這些因素已使細胞庫外包成為生物製藥領域的關鍵組成部分。

推動全球細胞庫外包市場發展的因素

推動全球細胞庫外包市場發展的關鍵因素之一是幹細胞療法日益普及的現象。幹細胞療法因其能夠治療多種疾病和病症，在再生醫學領域備受關注。隨著人們對這些治療方法的興趣日益成長，對可靠、高品質細胞株的需求也隨之增加，從而導致對細胞庫服務的需求不斷成長。這一趨勢正在推動細胞庫外包產業的成長，因為生物製藥公司和受託研究機構(CRO) 正在尋求高效且經濟的方式來生產和保存這些關鍵細胞株，以滿足不斷成長的治療需求。

全球細胞庫外包市場的限制因素

全球細胞庫外包市場面臨的一大挑戰是細胞庫服務的高成本。細胞庫流程的複雜性要求進行全面的測試和鑑定，以確保細胞株的安全性和質量，這導致對專用基礎設施和設備的大量投資。此外，監管機構對細胞株生產和儲存的嚴格規定也推高了成本。這種經濟負擔可能會阻礙細胞庫服務的廣泛應用，尤其是在醫療預算有限的發展中地區，這限制了人們獲得這些重要服務的機會。

全球細胞庫外包市場趨勢

受個人化醫療需求不斷成長的推動，全球細胞庫外包市場呈現顯著的成長趨勢。隨著醫療保健產業向基於個別基因譜的客製化治療模式轉變，細胞庫外包服務在提供滿足患者特定需求的客製化細胞產品方面發揮關鍵作用。該領域的企業正在加速採用先進技術，旨在提高基因匹配細胞的生產效率並促進標靶治療。這種對個人化治療的關注不僅提升了細胞庫在臨床應用中的重要性，也刺激了創新和投資，使市場能夠順應不斷發展的醫療保健模式，實現顯著成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球細胞庫外包市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 主細胞庫
• 病毒細胞庫
• 工作細胞庫

全球細胞庫外包市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 臍帶血細胞庫
• 成人幹細胞庫
• 誘導性多功能幹細胞庫
• 胚胎幹細胞庫

全球細胞庫外包市場規模（依細胞類型分類）及複合年成長率（2026-2033 年）

• 幹細胞
  • 臍帶血庫
  • 胚胎幹細胞庫
  • 成人幹細胞庫
  • 牙髓幹細胞庫
  • iPS細胞庫
• 非幹細胞

全球細胞庫外包市場規模按階段和複合年成長率分類（2026-2033 年）

• 銀行儲存
  • 主細胞庫保存
  • 工作細胞庫保存
  • 細胞儲存穩定性測試
• 細胞儲存穩定性測試
• 銀行準備
  • 主細胞庫製備
  • 細胞庫準備
• 銀行特徵分析與測試
  • 安全測試
  • 病毒細胞庫
  • 微生物細胞庫
  • 基因表現檢測
  • 核形態學檢查
  • 基因序列測定檢測

全球細胞庫外包市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Charles River Laboratories（USA）
• Lonza（Switzerland）
• Merck KGaA（Germany）
• SGS Societe Generale de Surveillance SA（Switzerland）
• Cryo-Cell International, Inc.（USA）
• LifeCell（India）
• WuXi AppTec（China）
• Eurofins Scientific（Luxembourg）
• Sartorius（Bio Outsource）（Germany）
• BSL Bioservice（Germany）
• Key Developments
• ViaCord（USA）
• StemCyte, Inc.（USA）
• Cryoviva Biotech Pvt. Ltd.（India）

結論與建議

Global Cell Banking Outsourcing Market size was valued at USD 15.59 Billion in 2024 and is poised to grow from USD 18.27 Billion in 2025 to USD 65.04 Billion by 2033, growing at a CAGR of 17.2% during the forecast period (2026-2033).

The global cell banking outsourcing market is poised for substantial growth, fueled by advancements in cryopreservation techniques and cell bank preparation methodologies. Increasing popularity of stem cell therapies, alongside the rising demand for monoclonal antibodies and effective biopharmaceuticals, significantly enhances this market. Furthermore, supportive government policies and technological innovations in cell line storage and characterization contribute to the momentum. Noteworthy collaborations among key players in the industry, particularly in research and development, are anticipated to further accelerate growth. The exploration of cryoprotective agents for improved tissue stability during cryopreservation also stands to positively influence the market landscape. Overall, the confluence of these factors positions cell banking outsourcing as a vital segment within the biopharmaceutical sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Banking Outsourcing Market Segments Analysis

Global Cell Banking Outsourcing Market is segmented by Type, Product, Cell Type, Phase and region. Based on Type, the market is segmented into Master Cell Banking, Viral Cell Banking and Working Cell Banking. Based on Product, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking and Embryonic Stem Cell Banking. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Phase, the market is segmented into Bank Storage, Cell Storage Stability Testing, Bank Preparation and Bank Characterization and Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Banking Outsourcing Market

A significant factor propelling the global cell banking outsourcing market is the heightened adoption of stem cell therapies, which are gaining traction in the realm of regenerative medicine due to their capability to address various diseases and disorders. As interest in these therapies escalates, so does the necessity for reliable and high-quality cell lines, consequently amplifying the demand for cell banking services. This trend stimulates the growth of the cell banking outsourcing sector, as biopharmaceutical companies and contract research organizations (CROs) look for efficient and cost-effective means to produce and preserve these essential cell lines, ensuring they meet the increasing therapeutic needs.

Restraints in the Global Cell Banking Outsourcing Market

A prominent challenge facing the global cell banking outsourcing market is the elevated expense associated with cell banking services. The intricate nature of the cell banking process necessitates comprehensive testing and characterization to guarantee the safety and quality of cell lines, leading to substantial investment in specialized infrastructure and equipment. Furthermore, the stringent regulations enforced by authorities regarding the production and storage of cell lines contribute to increased costs. This financial burden can hinder the widespread adoption of cell banking services, particularly in developing regions where healthcare budgets are constrained, thereby limiting access to these essential services.

Market Trends of the Global Cell Banking Outsourcing Market

The Global Cell Banking Outsourcing market is experiencing a significant trend driven by the escalating demand for personalized medicine. As healthcare shifts towards tailoring treatments to individual genetic profiles, cell banking outsourcing services are pivotal in providing customized cellular products that align with these unique patient needs. Companies in this sector are increasingly adopting advanced technologies aimed at enhancing the production of genetically matched cells, thereby facilitating targeted therapies. This focus on individualized treatment not only boosts the relevance of cell banks in clinical applications but also fosters innovation and investment, positioning the market for substantial growth in response to evolving healthcare paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Banking Outsourcing Market Size by Type & CAGR (2026-2033)

• Market Overview
• Master Cell Banking
• Viral Cell Banking
• Working Cell Banking

Global Cell Banking Outsourcing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Cord Cell Banking
• Adult Stem Cell Banking
• Induced Pluripotent Stem Cell Banking
• Embryonic Stem Cell Banking

Global Cell Banking Outsourcing Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Stem Cell
  • Cord Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-Stem Cell

Global Cell Banking Outsourcing Market Size by Phase & CAGR (2026-2033)

• Market Overview
• Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Cell Storage Stability Testing
• Bank Preparation
  • Master Cell Bank Preparation
  • Working Cell Bank Preparation
• Bank Characterization and Testing
  • Safety Testing
  • Viral Cell Banks
  • Microbial Cell Banks
  • Gene Expression Testing
  • Karyology Testing
  • Gene Sequencing Testing

Global Cell Banking Outsourcing Market Size & CAGR (2026-2033)

• North America (Type, Product, Cell Type, Phase)
  • US
  • Canada
• Europe (Type, Product, Cell Type, Phase)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Cell Type, Phase)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Cell Type, Phase)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Cell Type, Phase)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS Societe Generale de Surveillance SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius (Bio Outsource) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BSL Bioservice (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• ViaCord (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoviva Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations